Trustees Of The University Of Pennsylvania Rapt Therapeutics, Inc. Transaction History

Trustees Of The University Of Pennsylvania

$28.2 Million
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	BUY	$10.26 - $23.59 $102,918 - $236,631	10,031 New	10,031 $183,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

Vanguard Group Inc Valley Forge, PA

3.16M
Shares

$2.65 Million
0.0% of portfolio
Column Group LLC San Francisco, CA

2.68M
Shares

$2.25 Million
7.75% of portfolio
Black Rock Inc. New York, NY

2.44M
Shares

$2.05 Million
0.0% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

1.73M
Shares

$1.45 Million
0.42% of portfolio
Ponoi Management, LLC San Francisco, CA

1.6M
Shares

$1.34 Million
52.54% of portfolio

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $24.9M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of The University Of Pennsylvania, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of The University Of Pennsylvania with notifications on news.

Account